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INTRODUCTION
Gastric cancer is a worldwide disease with variable
incidence in different geographic areas. It remains the
second most common cancer in the world and it is be-
coming a serious problem in developing countries.1
Gastric cancer is distinguished into two forms, early
gastric cancer and advanced gastric cancer. Early
gastric cancer refers to invasion of the tumor limited to
the mucosal and submucosal layers, whether or not
regional lymph node metastases are present. 2  The
pathogenesis of gastric cancer is multi factorial, with both
environmental and host factors playing a major role in its
development. Among the risk factors for gastric cancer
are consumption of smoked and salted food; nitrites,
cigarette smoking; a lack of fiber in their diet, low socio-
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Palliative resection could not be performed because the tumor tightly adhered to adjacent structures.
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economic status; positive family history; A blood type;
hereditary cancer syndrome (familial adenoma polypo-
sis); Helicobacter pylori infection; and history of partial
gastrectomy.2 ,3
The classic clinical symptoms and findings of gastric
cancer are vague and non-specific, including epigastric
pain, vomiting, nausea, bloating, early satiety, weight loss,
abdominal mass, gastrointestinal bleeding, and sometimes
dysphagia. Early gastric cancer may have no clinical
symptoms. That is reason why most patients are
diagnosed with gastric cancer at advanced stages of the
disease.4  Gastroscopy is very crucial in making the
diagnosis of gastric cancer.
Treatment of gastric cancer is mainly surgery. Other
treatment modalities are chemotherapy and radiotherapy.
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There are two kinds of surgery: curative and non curative
or palliation. Early gastric cancer can be cured by non
surgical intervention like endoscopic mucosal resection
(EMR). In contrast, surgery for advanced gastric cancer
is merely palliation. It has been reported that patients
underwent palliative surgery had better prognoses than
those who did not.5 ,6 Inoperable patients and those with
metastatic disease have been subject to combination of
chemotherapy and radiotherapy. The effectiveness of this
therapeutic strategies is still controversial.7 ,8
CASE REPORT
The patient, Ms A, 23 years, was admitted to the
hospital with a chief complaint of nausea and vomiting
since 4 months prior to admission. At first, she usually
vomited 3-4 hours after meals. She also suffered
recurrent epigastric discomfort.  She lost her appetite
and lost a lot of weight in a short period of time.
Eventually, she vomited more often. She could hardly
eat any food because she vomited directly after
swallowing it. She reported no symptoms of
gastrointestinal bleeding such as hematemesis or
melena. The patient never had symptoms like this
before. Her elder sister died a few years earlier and had
similar symptoms as the patient.  Unfortunately, the
diagnosis had never been confirmed. The patient and
her family were of low socioeconomic status.
The patient was generally weak and cachectic.
Physical examination revealed vital signs within normal
range. The conjunctivae were pale, the sclera were not
jaundiced. Heart and lung examinations were within
normal range. The liver and spleen were not palpable.
An abdominal mass was palpable, with a dimension of 8
x 6 x 4 cm. It was hard, immobile, and was non-tender.
Superficial lymph nodes were not palpable.
Laboratory examination results were as follows: ESR
50 mm/hour; hemoglobin 11 g/dl; hematocryte 32 %; leu-
kocyte count 8000/mm; platelet count 485.000/mm;
ureum level 21mg/dL; creatinine level 0.7 mg/dL; blood
glucose level 87 mg/dL; SGOT 34 iu/mL; SGPT 32 iu/
mL; total bilirubin 0.6 mg/dL; alkaline phosphatase 57
iu/mL; albumin 2.6 mg/dL; globulin 4 mg/dL; cholinest-
erase 2.23; and CA19-9 level < 3 U/mL ( normal < 37
U/mL).
Endoscopy of the upper gastrointestinal tract
demonstrated esophagitis, with giant tumor mass
causing gastric outlet obstruction, that appear
edematous and fragile gastric mucosa. There were
nodular ulcerative and hemorrhagic lesions. Some parts
of the gaster were covered with fluid and indigested food.
The tumor mass was suggested to be malignancy in the
antrum. Nevertheless, the scope could still pass through.
Flocare was inserted by endoscopy. Abdominal CT scan
showed gastric carcinoma in the minor curvature and
gastric pylorus areas, with no signs of hepatic
metastasis or involvement of adjacent organs.
Histopathological examination demonstrated gastric
mucosa surrounded with tumor cells and mucinous lamina
propria. Scattered signet ring cells were present, but they
did not dominate the histological picture. The lesion was
concluded to be gastric mucinous carcinoma with a
differential diagnosis of signet ring cell carcinoma.  There
were no signs of Helicobacter pylori infection.
The patient was given supportive care for nutrition,
fluid and electrolyte balance. In the subsequent weeks,
obstruction caused by the tumor aggravated and we thus
Figure 1. Cancer of stomach Figure 2. Histopathological appreance gastric mucinous carcinoma
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performed a repeat endoscopy. It showed progression
of the tumor to the surrounding distal gaster. The
pylorus could not be identified. The naso-duodenal tube
could no longer be inserted. We immediately consulted
to the Department of Surgery and the patient was
prepared for surgical intervention. The tumor could not
be resectable and they decided to make jejunostomy to
allow enteral nutrition.
DISCUSSION
Gastric cancer is rare among young female. It is
usually found in older patients of over 55 years and is
more common in men.1  Data from the Department of
Pathology Anatomy of the Faculty of Medicine of the
University of Indonesia revealed 16 cases of gastric
carcinoma in Cipto Mangunkusumo hospital, Jakarta,
from January 2001 to December 2002. A study had
reported a worse outcome of esophagogastric carcinoma
in young patients compared to those who were older. 9
The pathogenesis of gastric cancer is multi factorial,
both genetic susceptibility and environmental factor play
a major role in its development. A positive family history
had not been confirmed in this case. However, if it were
true, it may also reflect exposure to similar
environmental factors beside genetic mechanism. In this
case, low socioeconomic status was a risk factor known
to be associated with gastric cancer.2 ,4,10 Most cases of
gastric cancer are first diagnosed at advanced stages.
Early gastric cancer usually has no or only minimal
clinical manifestation. Thus, early detection of the
disease is very difficult.1 ,2,6 Common symptoms are
weight loss, epigastric pain, vomiting, nausea, anorexia,
dysphagia, bloating, and regurgitation. It was often
initially misdiagnosed as dyspepsia syndrome. The
symptoms and signs of this patient such as nausea,
vomiting and abdominal mass reflected the obstruction
caused by advanced gastric cancer.
Histopathological features of gastric tumor may also
have prognostic value. In this patient, the gastric tumor
found was mucinous carcinoma. The gland-like
structures were lined by mucous-producing cells and their
secretions were retained in the lumen. It was concluded
to have been mucinous carcinoma, with a differential
diagnosis of signet ring cell carcinoma because scattered
signet ring cells were present but they did not dominate
the histological picture. The prognosis of mucinous
carcinoma is known to be poor.1 0,11
The treatment of gastric cancer depends on the stage
of the disease. Surgery is still a major treatment
modality for gastric cancer and could be curative or
palliative. Most patients are first diagnosed at advanced,
‘inoperable’ stages. In this case, the tumor had
progressively enlarged and caused obstruction of the
gastric outlet. Resection of the tumor is still recommended
for palliative treatment. Studies had reported that
patients underwent palliative surgery had a better
prognosis than those who did not.5 ,6 But the tumor was
not removed because it was found to closely adhere to
surrounding tissue and structures. Removal of the tumor
would be very difficult and carried major risks of
complications such as bleeding and perforation. Surgical
intervention performed to this patient was jejunostomy,
to allow enteral nutrition. A nasogastric tube was also
inserted to drain the physiological secretions of the    upper
gastrointestinal tract.
The prognosis of this patient was poor. No curative
treatment could be undertaken. The best supportive care
was the only treatment strategy, and was essential to
improve quality of life. The 5-year survival of patients
undergoing non-curative resection was reported to have
been only 5 %.5 ,6
REFERENCES
1. Bolan R. Tumors of the stomach. In : Yamada T, Alpers DH,
Laine L, Owyang C, Powell DH (editors). Textbook of gastro-
enterology, 3rd edition, Lippincot and Williams:
2. Chung RK. Benign and malignant tumors of the stomach. In:
Sivak M (editor). Gatroenterologic Endoscopy. 2nd edition. WB
Saunders Company.
3. Faraji EI, Frak B. Multifocal atrophic gastritis and gastric carci-
noma. Hematol Oncol Clin North Am 2003; 17: 487-504.
4. Itzkowitz SH. Gastrointestinal cancer. In: a core curriculum and
self assessment in gastroenterology and hepatology. Wilcox CN
(editor) DDSEP II. American Gastroenterology Association
2000.
5. Furukawa H, Imamura H, Kodera Y. The role of surgery in the
current treatment of gastric carcinoma. Gastric Cancer 2002;
suppl. 1:13-6.
6. Lukman. Peran pembedahan pada kanker lambung. Simposium
X Hematologi Onkologi Medik ‘Kemajuan dalam
penatalaksanaan keganasan gastrointestinal’. Hotel Borobudur
Jakarta 23 Agustus 2003.
7. Chung JH et al. salvage treatment for advanced gastric cancer
using combination of chemotherapy. Cancer research and treat-
ment 2002; 34 (5): 382-7.
8. Thomas AL, Byrne KO, Steward WP. Chemotherapy for up-
per gastrointestinal tumors. Post Grad Med J 2000; 76: 321-7.
9. Bowrey DJ et all. Outcome of esophagogastric carcinoma in
young patients. Post Grad med J 1999; 75: 22-6.
10. Lantz PE. The neoplastic stomach. In: Fenoglio-Preiser C,
Nofsinger A, Lantz PE, Listrom M (editors). Gastrointestinal
Pathology: an atlas and text. 2nd edition. Lippincot and Williams
1999. p 237-72.
11. Locke GR et al. Changes in the site and histologic-spesific inci-
dence of gastric cancer during 50 years period. Gastroenterol-
ogy 1995; 109: 1750-6.
